|
|
 |
 |
| Next Generation Sequencing Congress is administered by Osney Media. |
 |
|
|
 |
 |
 |
| Next Event |
 |
 |
Next Generation Sequencing Congress 2010
Monday 15th November 2010 to Tuesday 16th November 2010 London, UK
|
|
More
|
|
|
 |
 |
 |
|
Oxford Global Conferences’ strict delegate screening criteria and one to one meeting selection facility allow you to reach a large number of pre-qualified decision makers and make the most of your time at the event. |
|
Read More
|
|
|
| Speakers |
 |
 |
|
The Next Generation Sequencing Congress 2010 consists of a unique blend of presentations, panel discussions and one to one business meetings. If you have a cutting edge case study or a thought provoking presentation join us at the event.
|
|
Read More
|
|
|
|
 |
|
|
 |
| Featured Speakers |
 |
|
|
Mark Blaxter,
Principal Investigator, MRC - Scottish Hub, University of Edinburgh
|
 |
|
|
Stephanie Brooking,
European Segment Manager, Sequencing, Regional Marketing-Europe, Illumina
|
 |
|
|
Dr James Brown,
Manager Computational Biology for Infectious Diseases, GlaxoSmithKline
|
 |
|
|
Dr Francesca Ciccarelli,
European Oncology Institute, Milan, Italy
|
 |
|
|
Laura Clarke,
Scientific Programmer, EBI
|
 |
|
|
Dr Jonathan Coxhead,
Institute of Human Genetics, Newcastle University
|
 |
|
|
Dr Ann Curtis,
Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust
|
 |
|
|
Niek de Vries,
Team leader, Department Clinical Immunology & Rheumatology FOCIS & EULAR Center of Excellence, AMC Cambridge, UK
|
 |
|
|
Professor Peter Donnelly,
Principal Investigator, Director, Wellcome Trust Centre for Human Genetics
|
 |
|
|
Dr Joaquin Dopazo,
Head of the Bioinformatics and Genomics Department, Centro de Investigacion Principe Felipe
|
 |
|
|
David Dow,
Manager Computational Biology and Cellular Technologies, GlaxoSmithKline
|
 |
|
|
Marcus Droege,
Global Marketing Director, Genome Sequencing, Roche Applied Science
|
 |
|
|
Matthew Eldridge,
Head, Computational Biology Core at Cancer Research UK (Cambridge Research Institute), Cambridge UK
|
 |
|
|
Roberto Fabbretti,
Swiss Institute of Bioinformatics Genopode, University of Lausanne
|
 |
|
|
Aaron Golden,
Lecturer, Bioinformatics Research Group, Enabling Technologies, National Centre for Biomedical Engineering Science, NUI, Germany
|
 |
|
|
Neil Hall,
Principal Investigator, MRC- North England hub University of Liverpool
|
 |
|
|
Pawel Herzyk,
DNA, Arrays, Bioinformatics, Sir Henry, Wellcome Functional Genomics Facility, University of Glasgow
|
 |
|
|
Dr Heinz Himmelbauer,
Head of Sequencing Unit, Center for Genomic Regulation, Spain
|
 |
|
|
Paul J. Hurd,
Lecturer in Molecular Biology & Biochemistry, School of Biological and Chemical Sciences, Queen Mary University of London
|
 |
|
|
William E. Jack,
Research Director, New England Biolabs
|
 |
|
|
Eric Kemen,
Post Doctural Researcher, Sainsbury Laboratory
|
 |
|
|
Dr Karol Kozak,
Database Implementation, High Content Screening; RISC, Eth Zurich
|
 |
|
|
Niels Kruize,
Sales Director, KBiosciences Ltd
|
 |
|
|
Chris Lord,
Senior Staff Scientist, The Institute of Cancer Research, UK
|
 |
|
|
Dr Hendrik Marks,
Post Doctoral Researcher, Radboud University
|
 |
|
|
Dr Kalim Mir,
Research Fellow/Principal Investigator, The Wellcome Trust Centre for Human Genetics, University of Oxford
|
 |
|
|
Robert Nutter,
Sr. Staff Applications Scientist, SOLiD Transcriptomic Applications, Appled Biosystems
|
 |
|
|
Martin Pieprzyk,
Worldwide Product Manager, Fluidigm
|
 |
|
|
Senior Representative,
Quantum
|
 |
|
|
Senior Representative,
HP
|
 |
|
|
Dr Philippe Sanseau,
Head Computational Biology, GlaxoSmithKline
|
 |
|
|
Dr. Lori Snyder,
Senior Lecturer in Biotechnology, Kingston University
|
 |
|
|
Dr David Taylor
Discovery Platform Manager, Microbiology, Unilever R&D
|
 |
|
|
Jenny Taylor,
Programme Director, genetics and Pathology theme, Oxford Biomedical Research Centre, Wellcome Trust Centre for Human Genetics Oxford
|
 |
|
|
Dr Dan Turner,
Head of Sequencing Technology Department, Wellcome Trust Sanger Institute
|
 |
|
|
Dr Chen Wei,
Head of Genomics Platform, Berlin Institute for Medical Systems Biology, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany
|
 |
|
|
 |
|
|
|
 |
|